SNAP25 and Drooling: Since the 1990s, various clinical studies have confirmed the efficacy of injecting BTXA into the salivary glands to treat sialorrhea, a process that involves the cleavage of synaptosomal-associated protein 25 (SNAP-25) to inhibit acetylcholine release.